Research

Remdesivir proves effective

“Game-Changer” treatment for patients with COVID-19

“Game-Changer” treatment for patients with COVID-19

On April 29, 2020, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, reportedOpens in new window that data from an international clinical trial testing the broad-spectrum antiviral drug remdesivir in around 1,090 patients showed “quite good news” and should result in a new standard of care for COVID-19 patients.

Remdesivir was developed through an academic-corporate partnership between Gilead Sciences and the Baric Lab at the UNC Gillings School of Global Public HealthOpens in new window. The biopharmaceutical company sought the talents of a research team led by Ralph Baric,Opens in new window the William R. Kenan Jr. Distinguished Professor of Epidemiology, who has studied coronaviruses for more than 30 years and pioneered rapid-response approaches for the study of emerging viruses and the development of therapeutics.

“This is a game-changer for the treatment of patients with COVID-19,” Baric said upon hearing the results of the clinical trial. “Remdesivir provides an effective treatment strategy for the many infected individuals around the globe.”

Read the complete Carolina Story…Opens in new window

Carolina on the Frontlines

Learn more about Carolina’s ongoing COVID-19 research and what you can do to help.

Accelerate COVID-19 Research at Carolina

Carolina on the Frontlines

UNC-Chapel Hill is on the frontlines of the COVID-19 pandemic. View the ways you can immediately support Carolina researchers, caregivers and students who drive change, accelerate impact and provide a future for us all.

Support Carolina on the Frontlines

UNC Gillings School of Global Public Health

Readers Also Viewed...

Researcher
Research

Tracking a Virus Villain

Federal funding is supporting vital research by Carolina scientists.

Joe Brown poses in the foreground of a lab.
Environment

A Human Right

Investigating the link between gut infections and poor infrastructure in underserved rural communities in the U.S. South

Dr. Characklis teaching students
Environment

The 3 E’s: Environment, Economics and Engineering

Researching the intersection of environment, economics and engineering

Donald Fejfar in a lab
Research

Population-Based Work

Morehead-Cain Scholar studying food and water security in the Galapagos

Ashleigh Henry
Environment

Environmental Factors and Human Health

A Chancellor’s Science Scholar is researching the intersection between the environment and human health.

Research

A One-Stop Shop

“Carolina is literally a lab-bench-to-bedside one-stop shop.”